2-hydroxy-3-(4-hydroxyphenyl)prop-2-enoic acid

Metabolite details

Identifier

GQYBCIHRWMPOOF-YVMONPNESA-N

InChI Key

GQYBCIHRWMPOOF-YVMONPNESA-N

IUPAC name

2-hydroxy-3-(4-hydroxyphenyl)acrylic acid

Preferred name

2-hydroxy-3-(4-hydroxyphenyl)prop-2-enoic acid

INN name

—

Synonym

2-hydroxy-3-(4-hydroxyphenyl)propenoic acid

ChEBI

CHEBI:27683

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
• Multi-omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
• WT_vs_WT_Aco
• Control_vs_Lithogenic_Diet
• Control_vs_OXPA_Treatment
• Control_vs_Endometrial_Cancer
• Control_vs_CSD